Zimny Sebastian, Pohl Rebekka, Rein-Fischboeck Lisa, Haberl Elisabeth M, Krautbauer Sabrina, Weiss Thomas S, Buechler Christa
Department of Internal Medicine I, Regensburg University Hospital, Regensburg, Germany.
Children's University Hospital (KUNO), Regensburg University Hospital, Regensburg, Germany.
Exp Mol Pathol. 2017 Aug;103(1):1-8. doi: 10.1016/j.yexmp.2017.06.001. Epub 2017 Jun 15.
Chemokine (CC-motif) receptor-like 2 (CCRL2) is a decoy receptor and regulates the local responses of the chemokine chemerin. Recently our group has shown that the functional chemerin receptor, chemokine-like receptor 1 (CMKLR1), correlates with fibrosis and non-alcoholic steatohepatitis (NASH) score in males only. In our current study, we wanted to know whether CCRL2 shows similar correlations as CMKLR1. Therefore, we analyzed the hepatic expression of CCRL2 in murine NASH and in liver tissues obtained from 85 patients with non-alcoholic fatty liver disease (NAFLD) and 33 controls. CCRL2 mRNA was not significantly changed in murine and human NASH liver. CCRL2 mRNA levels were positively correlated with inflammation, fibrosis and NASH scores in the patients. Concordantly, CCRL2 was related to the mRNA levels of F4/80, transforming growth factor beta and alpha smooth muscle actin in murine NASH. In the human cohort, CCRL2 mRNA correlated with fibrosis score and CMKLR1 mRNA in both gender. CCRL2 mRNA was induced in the liver of type 2 diabetes and hypercholesterolemic patients, but still positively correlated with fibrosis score when these patients were excluded from calculations. Human hepatic stellate cells (HSC), hepatic sinusoidal endothelial cells and Kupffer cells (KC) express CCRL2 mRNA. TNF induces CCRL2 expression in HSC and lipopolysaccharide in KC suggesting that correlations identified in NAFLD patients are partly related to the activation of these cells.
趋化因子(CC基序)受体样2(CCRL2)是一种诱饵受体,可调节趋化因子chemerin的局部反应。最近我们小组发现,功能性chemerin受体趋化因子样受体1(CMKLR1)仅与男性的纤维化和非酒精性脂肪性肝炎(NASH)评分相关。在我们目前的研究中,我们想了解CCRL2是否显示出与CMKLR1相似的相关性。因此,我们分析了CCRL2在小鼠NASH以及从85例非酒精性脂肪性肝病(NAFLD)患者和33例对照获得的肝组织中的肝脏表达。CCRL2 mRNA在小鼠和人类NASH肝脏中无明显变化。CCRL2 mRNA水平与患者的炎症、纤维化和NASH评分呈正相关。同样,在小鼠NASH中,CCRL2与F4/80、转化生长因子β和α平滑肌肌动蛋白的mRNA水平相关。在人类队列中,CCRL2 mRNA在两性中均与纤维化评分和CMKLR1 mRNA相关。CCRL2 mRNA在2型糖尿病和高胆固醇血症患者的肝脏中被诱导,但当将这些患者排除在计算之外时,其仍与纤维化评分呈正相关。人肝星状细胞(HSC)、肝窦内皮细胞和库普弗细胞(KC)表达CCRL-2 mRNA。肿瘤坏死因子诱导HSC中CCRL2的表达,脂多糖诱导KC中CCRL2的表达,这表明在NAFLD患者中发现的相关性部分与这些细胞的激活有关。